Alaunos Therapeutics Inc Sustainability Reports
Alaunos Therapeutics, Inc. is a biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. The company focuses on non-hormonal, non-incretin target pathways to provide an alternative approach compared to traditional hormone-based treatments.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001SM7BJ6
3 reports from 2021 to 2024
Company Profile
Alaunos Therapeutics, Inc. is a biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. The company focuses on non-hormonal, non-incretin target pathways to provide an alternative approach compared to traditional hormone-based treatments.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
